FDA Will Have Risk-Based Import Screening System Up And Running Throughout U.S. By Year's End
This article was originally published in The Pink Sheet Daily
Executive Summary
Limited roll out of the PREDICT system shows it has been effective in identifying the riskier imports that should be the focus of inspectors' attention, Commissioner Hamburg tells House panel
You may also be interested in...
FDA’s PREDICT Import Screening System Working As Predicted
An initial look at data from the first year of the import screening system’s full operation finds PREDICT is effective in directing FDA inspectors to high-risk products, Deputy Associate Commissioner for Regulatory Affairs Steve Solomon says.
PDUFA Stars Aligning As House Draft Gives FDA Direct Authority Over Importers
Latest version of potential House user fee bill eliminates revisions to FDA’s mission statement and includes provisions for approving breakthrough technologies and destroying unsafe drug imports at the border.
FDA Enforcement Powers Remain In Limbo As User Fee Bill Glides Through Markup
Senate committee approves comprehensive user fee bill, but FDA authority to destroy some unsafe drug imports and track-and-trace provisions remain outstanding issues. Meanwhile, the House is going back to the drawing board on several provisions.